Haiwen Huang

Title: Haiwen Huang: Pharmaceutical Inventions and Patent Contributions.

Introduction

Haiwen Huang is a male inventor associated with Guangzhou, China. His patent work includes pharmaceutical compounds and drug synthesis, with 2 patents listed in the provided information.

Latest Patents

Huang’s listed patents include “Piperazine Derivatives and Application Thereof,” which describes a class of piperazine derivatives, including a compound represented by formula (III) or a pharmaceutically acceptable salt thereof.

His other listed patent, “Crystal Form of Macrocyclic Compound, and Preparation Method Therefor and Use Thereof,” concerns a crystal form of a macrocyclic compound and its preparation and use. The disclosed compound is (6R,16R)-9-fluoro-16-methyl-13-oxa-2,17,21,25-tetraazapentane[16.6.2.0⁰,⁰]dihexadecane-1(25),7,9,11,18(26),19,21,23-octane-19-carbonitrile. The patent identifies characteristic X-ray diffraction peaks at specified 2θ values and describes the crystal form as non-hygroscopic, stable, and having favorable pharmacokinetic properties.

Career Highlights

Huang’s reported company affiliations include HitGen, Inc., and Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., Baiyunshan Pharmaceutical General Factory. These affiliations connect his work with pharmaceutical research and development.

Collaborations

Jiansong Wang and Fei Qin are identified as Huang’s coworkers, reflecting professional connections in his pharmaceutical and patent-related work.

Conclusion

Haiwen Huang’s listed inventions focus on pharmaceutical compounds and their properties, including piperazine derivatives and a stable crystal form of a macrocyclic compound.